期刊
BRIEFINGS IN FUNCTIONAL GENOMICS
卷 12, 期 4, 页码 381-387出版社
OXFORD UNIV PRESS
DOI: 10.1093/bfgp/elt014
关键词
gut microbiota; obesity; metagenomics; 16S rRNA; Akkermansia; type 2 diabetes
资金
- FSR (fonds speciaux de recherche, Universite catholique de Louvain, Belgium)
- FRSM (Fonds Recherche Scientifique Medicale, Belgium)
- SFD (Societe Fancophone du Diabete, France)
- ARC (Action de Recherche Concertee, Belgium)
The distal gut harbours microbial communities that outnumber our own eukaryotic cells. The contribution of the gut microbiota to the development of several diseases (e.g. obesity, type 2 diabetes, steatosis, cardiovascular diseases and inflammatory bowel diseases) is becoming clear, although the causality remains to be proven in humans. Global changes in the gut microbiota have been observed by a number of culture-dependent and culture-independent methods, and while the latter have mostly included 16S ribosomal RNA gene analyses, more recent studies have utilized DNA sequencing of whole-microbial communities. Altogether, these high-throughput methods have facilitated the identification of novel candidate bacteria and, most importantly, metabolic functions that might be associated with obesity and type 2 diabetes. This review discusses the association between specific taxa and obesity, together with the techniques that are used to characterize the gut microbiota in the context of obesity and type 2 diabetes. Recent results are discussed in the framework of the interactions between gut microbiota and host metabolism.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据